Sacroiliitis and HLA. A clinical and genetical study

Area of Science:

• Immunogenetics
• Rheumatology
• Clinical Medicine

Background:

• Sacroiliitis (SI) is an inflammatory condition affecting the sacroiliac joints.
• The human leukocyte antigen B27 (HLA-B27) is a well-known genetic marker associated with various spondyloarthropathies.
• Understanding the genetic predisposition and familial aggregation of SI is crucial for diagnosis and management.

Purpose of the Study:

• To investigate the association between HLA-B27 positivity and the occurrence of sacroiliitis.
• To examine the familial aggregation of sacroiliitis in relation to HLA-B27 status.
• To determine if HLA-B27 status influences the clinical presentation and prognosis of sacroiliitis.

Main Methods:

• Patient cohort: 39 patients diagnosed with sacroiliitis (23 males, 16 females).
• Genetic typing: HLA-B27 status determined for all patients.
• Family study: 74 first-degree relatives of 26 probands were assessed for sacroiliitis.
• Clinical data collection: Onset of symptoms and gender prevalence were recorded.

Main Results:

• 17 out of 39 (43.6%) sacroiliitis patients were HLA-B27 positive.
• Sacroiliitis occurred in 20% of families with HLA-B27 positive probands versus 3.7% in families with HLA-B27 negative probands.
• In HLA-B27 positive families, sacroiliitis presented earlier and predominantly in males.
• In HLA-B27 negative families, sacroiliitis had a later onset and no significant gender preponderance.

Conclusions:

• HLA-B27 positivity is strongly associated with sacroiliitis and its familial occurrence.
• HLA-B27 typing has significant nosological and prognostic relevance in patients with sacroiliitis.
• Genetic factors, particularly HLA-B27, play a critical role in the pathogenesis and clinical expression of sacroiliitis.